At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PTIX Protagenic Therapeutics Inc
Trading 11-22 09:41:49 EST
0.6180
+0.0001
+0.02%
High0.6180
Low0.6180
Vol382.00
Open0.6180
D1 Closing0.6179
Amplitude0.00%
Mkt Cap4.20M
Tradable Cap3.45M
Total Shares6.79M
T/O229.92
T/O Rate0.01%
Tradable Shares5.58M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.